The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer

Urology. 1994 Oct;44(4):481-5. doi: 10.1016/s0090-4295(94)80043-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aged
  • Bone Neoplasms / complications
  • Bone Neoplasms / secondary*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Hormones / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Orchiectomy
  • Pain, Intractable / etiology
  • Pain, Intractable / radiotherapy*
  • Palliative Care / methods*
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy
  • Strontium Radioisotopes / therapeutic use*
  • Treatment Failure

Substances

  • Hormones
  • Strontium Radioisotopes